Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingfeng Liu

Showing results (311-320 of 330) with videos related to

Pageof 33
Sort By:
BMC Medicine|May 11, 2025
Discovery and validation of a novel dual-target blood test for the detection of hepatocellular carcinoma across stages from cirrhosisWenhao Teng, Hui Li, Hao Yang, et al.
International Journal of Surgery (London, England)|January 19, 2024
Impact of three-dimensional reconstruction visualization technology on short-term and long-term outcomes after hepatectomy in patients with hepatocellular carcinoma: a propensity-score-matched and inverse probability of treatment-weighted multicenter studyXiaojun Zeng, Haisu Tao, Yanchen Dong, et al.
Journal of Hepatology|November 21, 2017
Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resectionZhengqing Lei, Yong Xia, Anfeng Si, et al.
BMC Cancer|December 5, 2021
Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from ChinaYifan Chen, Hongzhi Liu, Jinyu Zhang, et al.
Scientific Reports|April 7, 2017
MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathwaysXingxue Yan, Zhendong Zhu, Shenmin Xu, et al.
Pain Research & Management|May 9, 2019
The Chinese Association for the Study of Pain (CASP): Expert Consensus on the Cervicogenic HeadacheHong Xiao, Baogan Peng, Ke Ma, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 10, 2023
Prevalence, clinical characteristics, and outcomes of spontaneous portosystemic shunt in patients with hepatitis B-related cirrhosis: A multicenter study from ChinaQiao Ke, Xueping Yu, Xuan Wang, et al.
Neoplasia (New York, N.Y.)|July 19, 2025
Hepatocellular carcinoma escapes immune surveillance through deceiving thymus into recalling peripheral activated CD8<sup>+</sup> T cellsQiaoting Hu, Xuefeng Wang, Yundan You, et al.
Ebiomedicine|May 17, 2018
Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition PathwayQifei Zou, Ying Hou, Haibo Wang, et al.
The Lancet. Gastroenterology & Hepatology|March 14, 2020
Adjuvant <sup>131</sup>I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trialJun Li, Jingliang Xing, Yefa Yang, et al.
Pageof 33

Showing results (311-320 of 330) with videos related to

Sort By:
Pageof 33
BMC Medicine|May 11, 2025
Discovery and validation of a novel dual-target blood test for the detection of hepatocellular carcinoma across stages from cirrhosisWenhao Teng, Hui Li, Hao Yang, et al.
International Journal of Surgery (London, England)|January 19, 2024
Impact of three-dimensional reconstruction visualization technology on short-term and long-term outcomes after hepatectomy in patients with hepatocellular carcinoma: a propensity-score-matched and inverse probability of treatment-weighted multicenter studyXiaojun Zeng, Haisu Tao, Yanchen Dong, et al.
Journal of Hepatology|November 21, 2017
Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resectionZhengqing Lei, Yong Xia, Anfeng Si, et al.
BMC Cancer|December 5, 2021
Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from ChinaYifan Chen, Hongzhi Liu, Jinyu Zhang, et al.
Scientific Reports|April 7, 2017
MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathwaysXingxue Yan, Zhendong Zhu, Shenmin Xu, et al.
Pain Research & Management|May 9, 2019
The Chinese Association for the Study of Pain (CASP): Expert Consensus on the Cervicogenic HeadacheHong Xiao, Baogan Peng, Ke Ma, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 10, 2023
Prevalence, clinical characteristics, and outcomes of spontaneous portosystemic shunt in patients with hepatitis B-related cirrhosis: A multicenter study from ChinaQiao Ke, Xueping Yu, Xuan Wang, et al.
Neoplasia (New York, N.Y.)|July 19, 2025
Hepatocellular carcinoma escapes immune surveillance through deceiving thymus into recalling peripheral activated CD8<sup>+</sup> T cellsQiaoting Hu, Xuefeng Wang, Yundan You, et al.
Ebiomedicine|May 17, 2018
Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition PathwayQifei Zou, Ying Hou, Haibo Wang, et al.
The Lancet. Gastroenterology & Hepatology|March 14, 2020
Adjuvant <sup>131</sup>I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trialJun Li, Jingliang Xing, Yefa Yang, et al.
Pageof 33